Oklo (NYSE:OKLO) Trading Down 6.2% After Analyst Downgrade

Oklo Inc. (NYSE:OKLO)’s stock price traded down 6.2% during trading on Thursday after UBS Group lowered their price target on the stock from $95.00 to $60.00. UBS Group currently has a neutral rating on the stock. Oklo traded as low as $51.10 and last traded at $51.8490. 7,185,868 shares were traded during mid-day trading, a decline of 32% from the average session volume of 10,524,670 shares. The stock had previously closed at $55.27.

Other analysts have also issued research reports about the company. Zacks Research upgraded Oklo from a “strong sell” rating to a “hold” rating in a report on Thursday, March 19th. The Goldman Sachs Group decreased their price objective on Oklo from $91.00 to $65.00 and set a “neutral” rating for the company in a research note on Wednesday, March 18th. Needham & Company LLC cut their target price on Oklo from $135.00 to $73.00 and set a “buy” rating on the stock in a research note on Wednesday, March 18th. Barclays reduced their target price on shares of Oklo from $146.00 to $82.00 and set an “overweight” rating for the company in a report on Monday, February 23rd. Finally, B. Riley Financial cut their price objective on shares of Oklo from $129.00 to $92.00 and set a “buy” rating on the stock in a research report on Wednesday, March 18th. Two equities research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $84.30.

Insider Buying and Selling at Oklo

In other Oklo news, insider William Carroll Murphy Goodwin sold 2,820 shares of the firm’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $56.69, for a total value of $159,865.80. Following the completion of the sale, the insider owned 15,991 shares of the company’s stock, valued at approximately $906,529.79. This trade represents a 14.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jacob Dewitte sold 72,960 shares of the business’s stock in a transaction dated Friday, March 13th. The stock was sold at an average price of $60.00, for a total value of $4,377,600.00. Following the sale, the chief executive officer owned 751,533 shares in the company, valued at $45,091,980. The trade was a 8.85% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 1,222,424 shares of company stock worth $100,739,512. 18.90% of the stock is owned by insiders.

Key Stories Impacting Oklo

Here are the key news stories impacting Oklo this week:

• Positive Sentiment: Regulatory progress for the Aurora reactor program was reported, suggesting advancement on licensing milestones that de‑risk the company’s flagship project and its timeline to commercial revenue. Regulatory progress for Aurora
• Positive Sentiment: Oklo completed the acquisition of Atomic Alchemy to enter domestic production of medical and industrial isotopes, diversifying revenue potential beyond reactors and shortening a path to cash flow. The company also reiterated reactor progress in the same update. Oklo Acquisition And Reactor Progress Reframe Long Term Investor Debate
• Positive Sentiment: CEO and co‑founder Jacob DeWitte was appointed to the President’s Council of Advisors on Science and Technology (PCAST), a high‑profile government advisory role that can improve regulatory access and legitimacy for advanced nuclear projects. Oklo Co-Founder and CEO Appointed to Serve on President’s Council of Advisors on Science and Technology
• Neutral Sentiment: Analysts remain conflicted on Oklo alongside other utilities/energy names, reflecting divergent views on commercialization timelines and regulatory risk that increase short‑term volatility. Analysts Conflicted on These Utilities Names: Oklo Inc (OKLO) and PG&E (PCG)
• Neutral Sentiment: Comparative coverage with peers (e.g., Montauk Renewables) has appeared, useful for investors benchmarking Oklo’s valuation and business model but not a direct positive/negative catalyst. Critical Comparison: Montauk Renewables (NASDAQ:MNTK) and Oklo (NYSE:OKLO)
• Negative Sentiment: UBS cut its price target from $95 to $60 and set a “neutral” rating, signaling lower near‑term upside and contributing to selling pressure. Benzinga
• Negative Sentiment: B. Riley trimmed its price target to $92, another downward analyst revision that likely dampened sentiment despite longer‑term growth narratives. OKLO Price Target Trimmed to $92

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. NBC Securities Inc. lifted its stake in shares of Oklo by 75.0% during the fourth quarter. NBC Securities Inc. now owns 350 shares of the company’s stock worth $25,000 after buying an additional 150 shares during the period. GAMMA Investing LLC increased its position in shares of Oklo by 356.3% in the 4th quarter. GAMMA Investing LLC now owns 365 shares of the company’s stock valued at $26,000 after acquiring an additional 285 shares during the period. Armstrong Advisory Group Inc. acquired a new position in shares of Oklo in the 3rd quarter valued at $27,000. Elevation Point Wealth Partners LLC purchased a new position in Oklo in the 2nd quarter worth $28,000. Finally, Gables Capital Management Inc. purchased a new position in Oklo in the 3rd quarter worth $28,000. Institutional investors and hedge funds own 85.03% of the company’s stock.

Oklo Trading Down 3.1%

The stock has a 50-day simple moving average of $68.12 and a 200 day simple moving average of $93.99. The company has a market cap of $8.72 billion, a price-to-earnings ratio of -69.75 and a beta of 0.80.

Oklo (NYSE:OKLO) last announced its quarterly earnings data on Tuesday, March 17th. The company reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.10). During the same quarter last year, the business earned ($0.74) earnings per share. As a group, research analysts forecast that Oklo Inc. will post -8.2 EPS for the current fiscal year.

Oklo Company Profile

Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.

The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.